SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-205989
Filing Date
2018-06-28
Accepted
2018-06-27 18:09:34
Documents
3
Period of Report
2018-06-25
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d837627d8k.htm 8-K 17100
2 EX-3.1 d837627dex31.htm EX-3.1 25430
3 EX-3.2 d837627dex32.htm EX-3.2 102282
  Complete submission text file 0001193125-18-205989.txt   145981
Mailing Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET STE 1800 CHICAGO IL 60601 512-498-2670
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38536 | Film No.: 18922736
SIC: 2834 Pharmaceutical Preparations